AU2020272037B2 - Compositions and methods for analyte detection using bioluminescence - Google Patents

Compositions and methods for analyte detection using bioluminescence

Info

Publication number
AU2020272037B2
AU2020272037B2 AU2020272037A AU2020272037A AU2020272037B2 AU 2020272037 B2 AU2020272037 B2 AU 2020272037B2 AU 2020272037 A AU2020272037 A AU 2020272037A AU 2020272037 A AU2020272037 A AU 2020272037A AU 2020272037 B2 AU2020272037 B2 AU 2020272037B2
Authority
AU
Australia
Prior art keywords
target analyte
analyte binding
bioluminescent
binding agent
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020272037A
Other languages
English (en)
Other versions
AU2020272037A1 (en
Inventor
Melanie Dart
Lance Encell
Mary Hall
Robin Hurst
Emily JOST
Virginia Kincaid
Thomas Kirkland
Thomas Machleidt
Thomas Smith
Hui Wang
Keith Wood
Zhiyang ZENG
Wenhui Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of AU2020272037A1 publication Critical patent/AU2020272037A1/en
Application granted granted Critical
Publication of AU2020272037B2 publication Critical patent/AU2020272037B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/103—Nucleic acid detection characterized by the use of physical, structural and functional properties luminescence

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2020272037A 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence Active AU2020272037B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962832052P 2019-04-10 2019-04-10
US62/832,052 2019-04-10
PCT/US2020/027711 WO2020210658A1 (en) 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence

Publications (2)

Publication Number Publication Date
AU2020272037A1 AU2020272037A1 (en) 2021-12-02
AU2020272037B2 true AU2020272037B2 (en) 2025-11-27

Family

ID=72751365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020272037A Active AU2020272037B2 (en) 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence

Country Status (11)

Country Link
US (2) US20200386748A1 (enExample)
EP (1) EP3953374A4 (enExample)
JP (2) JP7645812B2 (enExample)
KR (1) KR20220007058A (enExample)
CN (1) CN113891895A (enExample)
AU (1) AU2020272037B2 (enExample)
BR (1) BR112021020354A2 (enExample)
CA (1) CA3135195A1 (enExample)
IL (1) IL287261A (enExample)
SG (1) SG11202110773RA (enExample)
WO (1) WO2020210658A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7713448B2 (ja) * 2019-11-27 2025-07-25 プロメガ コーポレイション 多分子ルシフェラーゼペプチド及びポリペプチド
US20220396830A1 (en) * 2021-05-13 2022-12-15 Promega Corporation Bioluminescent detection of dna synthesis
WO2023028175A1 (en) * 2021-08-24 2023-03-02 Kaya17 Inc. System and method for detecting presence of a target bioparticle in a sample via a vertical flow assay
CN113786873B (zh) * 2021-08-31 2022-09-23 广西横县张一元饮品有限公司 一种用于食品安全检测的试管
CN118043668A (zh) * 2021-09-29 2024-05-14 富士胶片株式会社 免疫层析试剂盒及检查装置
CN114231401B (zh) * 2022-02-21 2022-05-03 北京芯迈微生物技术有限公司 一种核酸检测试剂盒及检测方法
WO2023200703A1 (en) * 2022-04-15 2023-10-19 Siemens Healthcare Diagnostics Inc. Creatinine lateral flow assay devices and methods of production and use thereof
GB2619059A (en) * 2022-05-26 2023-11-29 Univ Leeds Innovations Ltd Split reporter complex
WO2024129040A1 (en) * 2022-12-16 2024-06-20 T.C Ankara Universitesi Rektorlugu A card test for the hallucinogenic psilocybin molecule that allows the diagnosis of toxic mushrooms and mushroom toxicities
CN116218907B (zh) * 2023-02-20 2025-04-22 复旦大学附属中山医院 带有HiBiT新型报告基因的肠道病毒感染性克隆及其构建方法和应用
US20240343906A1 (en) * 2023-04-12 2024-10-17 Promega Corporation Poloxamer-stabilized reagents
WO2025024530A1 (en) * 2023-07-25 2025-01-30 The General Hospital Corporation Aldehyde binding optical imaging probes methods of use thereof
CN118033130B (zh) * 2024-01-19 2024-07-30 武汉科技大学 同时检测艾滋病、梅毒和丙肝的表面、微孔板、组件、方法及应用
CN118344492B (zh) * 2024-05-07 2025-03-11 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种纳米荧光素酶融合抗原在非洲猪瘟病毒抗体检测中的应用
CN118255903B (zh) * 2024-05-07 2025-03-11 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种检测非洲猪瘟病毒抗体的融合抗原、制备方法及检测试剂盒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014151736A1 (en) * 2013-03-15 2014-09-25 Promega Corporation Activation of bioluminescence by structural complementation
WO2018212322A1 (ja) * 2017-05-19 2018-11-22 国立大学法人 熊本大学 遺伝性腎疾患アルポート症候群治療薬に係る評価系

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423290A (en) * 1966-08-03 1969-01-21 Nasa Lyophilized reaction mixtures
US6045254A (en) * 1996-12-26 2000-04-04 M.L.I.S. Projects Ltd. Container having two or more compartments
US7118878B1 (en) * 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
US7741067B2 (en) * 2002-12-23 2010-06-22 Promega Corporation Luciferase-based assays
US7829347B2 (en) 2005-08-31 2010-11-09 Kimberly-Clark Worldwide, Inc. Diagnostic test kits with improved detection accuracy
EP2215450B1 (en) * 2006-02-21 2013-07-31 Nexus DX, Inc. Methods and compositions for analyte detection
CA2894435A1 (en) 2012-12-12 2014-06-19 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US10067149B2 (en) * 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US9969991B2 (en) * 2014-09-12 2018-05-15 Promega Corporation Internal protein tags
EP4455668A3 (en) * 2015-02-05 2025-02-19 Promega Corporation Luciferase-based thermal shift assays
US20170328896A1 (en) * 2016-02-19 2017-11-16 Insight Instruments, Inc. Assay systems for point of care detection of ocular analytes
US10634680B2 (en) * 2016-04-26 2020-04-28 University Of Utah Research Foundation Target-binding activated split reporter systems for analyte detection and related components and methods
WO2018148489A1 (en) 2017-02-09 2018-08-16 Promega Corporation Analyte detection immunoassay

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014151736A1 (en) * 2013-03-15 2014-09-25 Promega Corporation Activation of bioluminescence by structural complementation
US20140348747A1 (en) * 2013-03-15 2014-11-27 Promega Corporation Activation of bioluminescence by structural complementation
WO2018212322A1 (ja) * 2017-05-19 2018-11-22 国立大学法人 熊本大学 遺伝性腎疾患アルポート症候群治療薬に係る評価系

Also Published As

Publication number Publication date
CN113891895A (zh) 2022-01-04
JP2022526013A (ja) 2022-05-20
EP3953374A1 (en) 2022-02-16
AU2020272037A1 (en) 2021-12-02
CA3135195A1 (en) 2020-10-15
JP2025133108A (ja) 2025-09-10
BR112021020354A2 (pt) 2021-12-14
WO2020210658A1 (en) 2020-10-15
US20250264464A1 (en) 2025-08-21
SG11202110773RA (en) 2021-10-28
US20200386748A1 (en) 2020-12-10
JP7645812B2 (ja) 2025-03-14
IL287261A (en) 2021-12-01
KR20220007058A (ko) 2022-01-18
EP3953374A4 (en) 2023-06-07

Similar Documents

Publication Publication Date Title
AU2020272037B2 (en) Compositions and methods for analyte detection using bioluminescence
Nasir et al. Fluorescence polarization: an analytical tool for immunoassay and drug discovery
JP4968611B2 (ja) 免疫抑制剤の改善された測定法
US7141436B2 (en) Immunoassay and reagents and kits for performing the same
WO2015039423A1 (zh) 生物标记物的保存液、试剂和方法
JP2010091576A (ja) クロマトグラフィーアッセイシステム
WO2011057347A1 (en) Analyte detection
Hayat et al. Development of a novel label-free amperometric immunosensor for the detection of okadaic acid
JP2011241206A (ja) 標識抗体の安定化方法
Tang et al. Hemin/G-quadruplex-based DNAzyme concatamers as electrocatalysts and biolabels for amplified electrochemical immunosensing of IgG1
WO2007111847A2 (en) Use of additives for the reduction of non-specific binding in assays
CN104169710A (zh) 用于时间分辨荧光免疫测定检验的方法和装置
Mechaly et al. A novel homogeneous immunoassay for anthrax detection based on the AlphaLISA method: detection of B. anthracis spores and protective antigen (PA) in complex samples
US11802881B2 (en) Saturation binding ratiometric assay
BR112014020513B1 (pt) Métodos e sistemas para amplificação de sinal de bioensaios
Liu et al. Highly sensitive microplate chemiluminescence enzyme immunoassay for the determination of staphylococcal enterotoxin B based on a pair of specific monoclonal antibodies and its application to various matrices
US20200209230A1 (en) Methods and compositions relating to small molecule analyte assays
Kumar et al. Magnetic capture from blood rescues molecular motor function in diagnostic nanodevices
JP4486059B2 (ja) 免疫測定用ラテックス組成物
Litvinov et al. Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation
US20250277787A1 (en) Enhanced lateral flow assays and devices for detecting analytes in blood samples
US20160257988A1 (en) Indicator Molecules For Use In Detecting Enzyme Cleavage Activity
JP4068259B2 (ja) 免疫測定方法及び乾式免疫測定試薬
JP4028645B2 (ja) 化学発光酵素免疫測定方法
Nazem Viral Nanoparticles as Lateral Flow Assay Reporters: Analysis of Capture Kinetics, Stabilization, and Detection In Blood